This video examines the role of radiation therapy in early-stage lung cancer and some of the data comparing stereotactic ablative radiotherapy vs surgery in these patients.
In this video Alexander Louie, MD, PhD, MSc, of the London Health Sciences Centre in Canada, discusses the role of stereotactic ablative radiotherapy (SABR) in early-stage lung cancer patients who are not eligible for surgery, some of the literature about late effects of radiotherapy, and data comparing SABR vs surgery.
Louie gave a presentation on this topic at the 2017 Multidisciplinary Thoracic Cancers Symposium.
Eric Ko on Combining Radiation Therapy With Immunotherapy to Treat Non–Small-Cell Lung Cancer
September 18th 2018ONCOLOGY spoke with Eric Ko, MD, PhD, who recently published a review article with his colleagues on strategies for combining radiation therapy with immunotherapy for the treatment of non–small-cell lung cancer.